Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Teva Pharmaceuticals Stops Making Mebendazole
Teva Pharmaceuticals will no longer make and distribute Mebendazole 100 mg Tablets. Mebendazole is an antiworm medication that kills parasites. It is used to treat roundworm, hookworm, pinworm, whipworm, and other worm infections. This product is not discontinued or withdrawn for safety or efficacy reasons. The Mebendazole 100 mg Tablets currently available in pharmacies can continue to be dispensed and taken until their expiration date. For more information, please visit: http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM277319.pdf
Learn More

FDA Continues Review of the Risk of Blood Clots in Women Taking Birth Control Pills Containing Drospirenone
The U.S. Food and Drug Administration (FDA) has released a report summarizing the findings of an FDA-funded study that evaluated the risk of blood clots in users of several different hormonal birth control products (contraceptives). This is a follow-up to a communication from the FDA on September 26, 2011 which notified the public that the FDA remains concerned about the potential increased risk of blood clots with the use of drospirenone-containing birth control pills. Birth control pills containing drospirenone include YAZ (generics – Gianvi and Loryna), Yasmin (generics – Ocella, Syeda, and Zarah), Beyaz, and Safyral. The FDA's review of blood clots related to drospirenone-containing birth control pills is ongoing and the FDA will continue to update the public as new information becomes available. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/ucm277346.htm To view the MediGuard Safety Alert about the FDA Drug Safety Communication posted on 9/26/2011, please visit: https://www.mediguard.org/alerts/alert/1637.html
Learn More

Date Published Title Drug Source
2011-10-28 Teva Pharmaceuticals Stops Making Mebendazole Mebendazole FDA
2011-10-27 FDA Continues Review of the Risk of Blood Clots in Women Taking Birth Control Pills Containing Drospirenone Drospirenone with Ethinyl Estradiol FDA
2011-10-25 FDA: Xigris [drotrecogin alfa (activated)] Withdrawn From Market Due to Failure to Show Benefit FDA
2011-10-24 FDA Issues Safety Review Update on Chantix and Mental Health Adverse Effects Varenicline FDA
2011-10-22 Nostrilla Nasal Decongestant: Recall due to Bacterial Contamination Oxymetazoline Manufacturer
2011-10-21 FDA Updates Information about the Drug Interaction Between Methylene Blue and Certain Certain Medicines for Depression, Anxiety, Bipolar Disorder, Insomnia Methylene Blue FDA
2011-10-21 FDA Updates Information about the Drug Interaction Between Linezolid (Zyvox) and Certain Certain Medicines for Depression, Anxiety, Bipolar Disorder, Insomnia Linezolid FDA
2011-10-20 Sanofi-Aventis Announces Shortage of Apidra SoloSTAR Pens Insulin Glulisine Manufacturer
2011-10-18 Study Links Vitamins to Increased Risk Of Death In Older Women Zinc MediGuard CRT
2011-10-17 Study Links High Doses of Vitamin E to Possible Increase in Prostate Cancer Risk Vitamin E MediGuard CRT
2011-10-11 Sprycel Linked To Raised Blood Pressure In The Lungs Dasatinib FDA
2011-10-03 Online Guide For Using Pain Relievers Safely Acetaminophen FDA
2011-09-26 The FDA Continues to Be Concerned about the Increase Risk of Blood Clots with YAZ (generics – Gianvi and Loryna), Yasmin (generics – Ocella, Syeda, and Zarah), Beyaz, and Safyral Drospirenone with Ethinyl Estradiol FDA
2011-09-22 Users of Primatene Mist Will Need a Prescription Product to Treat Their Asthma Epinephrine FDA
2011-09-16 Qualitest Pharmaceuticals Recalls Birth Control Pills Due To Packaging Error that May Increase Risk of Unintended Pregnancies Desogestrel with Ethinylestradiol Manufacturer
2011-09-16 FDA Warns: Abnormal Heart Rhythms May Be Associated with Use of Zofran (Ondansetron) Ondansetron FDA
2011-09-08 Pure Encapsulations, Incorporated Recalls Prenatal Nutrients Products Prenatal Vitamins FDA
2011-09-07 FDA Updates Labels for Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), and Simponi (golimumab) Etanercept FDA
2011-09-07 FDA Warns of Infection Risk from Repackaged Avastin Injections For Eye Disease Bevacizumab FDA
2011-09-01 FDA Warns: Serious Allergic Reactions Reported with the Use of Saphris (Asenapine Maleate) Asenapine FDA
Back to Consumer Med Safety